Back to Novo Holdings A/S
Q2 2026 13F filing
Updated 27 days ago25 disclosed positions worth $1.7B
Portfolio value
$1.7B
Total holdings
25
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-08-14
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | E EWTX EDGEWISE THERAPEUTICS INC | $217.4M | 5.35M | 12.62% | — |
| 2 | A ASMLF ASML HOLDING N V | $188.9M | 94.9K | 10.97% | — |
| 3 | C COAG HEMAB THERAPEUTICS HLDGS INC | $153.6M | 4.18M | 8.92% | — |
| 4 | B BXDIF BROOKFIELD CORP | $149.5M | 3.50M | 8.68% | — |
| 5 | M MPLT MAPLIGHT THERAPEUTICS INC | $132.1M | 3.69M | 7.67% | — |
| 6 | M MIRM MIRUM PHARMACEUTICALS INC | $131.7M | 1.13M | 7.65% | — |
| 7 | A AVLN AVALYN PHARMACEUTICALS INC | $127.8M | 3.88M | 7.42% | — |
| 8 | C CRM SALESFORCE INC | $61.6M | 393.2K | 3.58% | — |
| 9 | ? N/A ARRIVENT BIOPHARMA INC | $52.1M | 1.50M | 3.03% | — |
| 10 | E ELVN ENLIVEN THERAPEUTICS INC | $50.8M | 1.00M | 2.95% | — |
| 11 | C CRNX CRINETICS PHARMACEUTICALS IN | $49.4M | 1.32M | 2.87% | — |
| 12 | P PHVS PHARVARIS N V | $48.4M | 1.40M | 2.81% | — |
| 13 | F FND FLOOR & DECOR HLDGS INC | $47.3M | 797.0K | 2.75% | — |
| 14 | P PCVX VAXCYTE INC | $46.5M | 800.0K | 2.70% | — |
| 15 | F FDMT 4D MOLECULAR THERAPEUTICS IN | $43.2M | 3.25M | 2.51% | — |
| 16 | V VRDN VIRIDIAN THERAPEUTICS INC | $39.2M | 2.13M | 2.28% | — |
| 17 | C CLDX CELLDEX THERAPEUTICS INC NEW | $38.1M | 1.02M | 2.21% | — |
| 18 | A ALMS ALUMIS INC | $31M | 1.10M | 1.80% | — |
| 19 | X XENE XENON PHARMACEUTICALS INC | $29.3M | 485.4K | 1.70% | — |
| 20 | B BBAAY ALIBABA GROUP HLDG LTD | $24.7M | 257.3K | 1.43% | — |
| 21 | D DYN DYNE THERAPEUTICS INC | $21.3M | 960.4K | 1.24% | — |
| 22 | ? N/A BRIDGEBIO ONCOLOGY THERAPEUT | $17.1M | 2.25M | 1.00% | — |
| 23 | I INSM INSMED INC | $12.9M | 120.7K | 0.75% | — |
| 24 | M MQ MARQETA INC | $7.2M | 441.6K | 0.42% | — |
| 25 | ? N/A LANZATECH GLOBAL INC | $1.1M | 158.1K | 0.06% | — |